Rockwell Automation, Inc. supports the pharmaceutical and biopharmaceutical manufacturing industries with the launch of its latest MES solution.

Rockwell Automation recently released FactoryTalk® PharmaSuite® 12.00, its next-generation manufacturing execution system (MES) solution for the pharmaceutical and biopharmaceutical industries.

The pharmaceutical and biopharmaceutical industries face two challenges: improving production efficiency through digitalization and complying with stringent regulations.

To this end, Rockwell Automation supports more flexible and efficient production operations through PharmaSuite 12.00 based on a modular architecture.

In particular, it provides deployment options that support cloud, on-premise, and hybrid environments, allowing for customized application according to the size of the company, and is designed to reduce verification costs and time by adding automated setup and enhanced cybersecurity functions.

PharmaSuite® 12.00's main features are: △Cloud-based deployment △Support for Kubernetes environment for fast and stable system construction △Global scalability and centralized management △Configuration automation and production optimization △Newly introduced MICKA configuration automation tool simplifies installation and verification process △△Increased operational efficiency in a regulated environment by reducing repetitive tasks △Enhanced cybersecurity and data protection △Enhanced compliance and data integrity by applying a secure development process △Providing an upgrade engine that can automatically apply the latest features and security patches △Flexible operation through modular design △Design changes and expansion possible according to the production environment △Easy global management with a standardized system, etc.

“PharmaSuite 12.00 redefines performance, security, compliance and scalability,” said Martin Petrick, business manager, MES, Rockwell Automation. “With a variety of deployment options, including cloud, manufacturers can scale operations more quickly and flexibly.”